Your session is about to expire
← Back to Search
Immulina Biomarker Identification for Supplement Intake Verification
Study Summary
This trial is testing if a natural dietary supplement can be used to help verify if a person has ingested it or not.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have a serious illness that has just recently developed.You are taking regular medications for a long-term illness.You must be in good health.You are currently pregnant or breastfeeding.You are between 18 and 50 years old, regardless of gender.
- Group 1: Immulina Dietary Supplementation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does my profile meet the predetermined criteria to partake in this research?
"This clinical trial is admitting 20 people aged 18-50 who have adherence, patient. Additionally, the accepted applicants must meet several other requirements: gender (male or female), use of contraception if applicable, and overall good health."
Is this research program open to people of a younger age?
"This medical trial only seeks patients aged 18 to 50, whereas other research projects in the same field are recruiting those below 18 and above 65. Specifically, 4 studies cater to younger individuals while 10 focus on senior citizens."
Are there any open enrolment slots left in this research?
"By referencing clinicaltrials.gov, it can be determined that this study is not currently recruiting patients; the trial was created on October 1st 2022 and updated lastly on September 28th 2022. Even so, there are 14 alternative trials actively seeking participants presently."
Share this study with friends
Copy Link
Messenger